Digital authentication specialist
AlpVision has said its revenues increased by 10 per cent in 2011,
suggesting that brand owners are continuing to invest in security
features for the their product despite the tough financial
While the privately-held firm does not disclose financial figures, it has also pointed to "solid" growth in its earnings before interest, taxes, depreciation, and amortization (EBITDA) for the year, positioning it for an expansion beyond its traditional focus on the pharmaceutical and tobacco industries in 2012.
The past year was notable for three accomplishments, including the roll-out of its digital imaging-based Fingerprint technology for customers in the pharmaceutical industry, including Debiopharm (see also AlpVision signs two more pharma customers).
2011 also saw the company launch a portable quality control device that gives packaging printers and converters a simple way of detecting the presence of its Cryptoglyph invisible marking technology, and an iPhone4 app for moulded part identification.
Meanwhile, AlpVision's head of corporate communications Roland Meylan has retired after six and a half year's service. All of us at SecuringPharma wish him all the best for the future, and extend a warm welcome to Jennifer Yribar, who will succeed Roland in the role.